DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 02 · Volume 34 · May 2014 DOI: 10.1055/s-004-27077 Drug-Induced Liver Injury Guest Editors, Naga Chalasani, MD, and Paul H. Hayashi, MD, MPH

Foreword

  • 113
    Chalasani, Naga; Hayashi, Paul H.:

    Slow but Steady Progress in a Field with Many Knowledge Gaps

  • 115
    Björnsson, Einar S.:

    Epidemiology and Risk Factors for Idiosyncratic Drug-Induced Liver Injury

  • 123
    Urban, Thomas J.; Daly, Ann K.; Aithal, Guruprasad P.:

    Genetic Basis of Drug-Induced Liver Injury: Present and Future

  • 134
    Hayashi, Paul H.; Fontana, Robert J.:

    Clinical Features, Diagnosis, and Natural History of Drug-Induced Liver Injury

  • 145
    Devarbhavi, Harshad; Andrade, Raúl J.:

    Drug-Induced Liver Injury Due to Antimicrobials, Central Nervous System Agents, and Nonsteroidal Anti-Inflammatory Drugs

  • 162
    Bahirwani, Ranjeeta; Reddy, K. Rajender:

    Drug-Induced Liver Injury due to Cancer Chemotherapeutic Agents

  • 172
    Navarro, Victor J.; Lucena, M. Isabel:

    Hepatotoxicity Induced by Herbal and Dietary Supplements

  • 194
    deLemos, Andrew S.; Foureau, David M.; Jacobs, Carl; Ahrens, Will; Russo, Mark W.; Bonkovsky, Herbert L.:

    Drug-Induced Liver Injury with Autoimmune Features

  • 205
    Amacher, David E.; Chalasani, Naga:

    Drug-Induced Hepatic Steatosis

  • 215
    Avigan, Mark I.:

    DILI and Drug Development: A Regulatory Perspective

  • 227
    Regev, Arie:

    Drug-Induced Liver Injury and Drug Development: Industry Perspective

    • Diagnostic Problems in Hepatology

  • 240
    Ghabril, Marwan; Vuppalanchi, Raj:

    Drug-Induced Nodular Regenerative Hyperplasia

  • 246
    Levine, Calley; Trivedi, Anshu; Thung, Swan N.; Perumalswami, Ponni V.:

    Severe Ductopenia and Cholestasis from Levofloxacin Drug-Induced Liver Injury: A Case Report and Review

    • Erratum

  • 252
    Welzel, Tania Mara; Zeuzem, Stefan:

    Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue